Warning: The NCBI web site requires JavaScript to function. more...
Colchicine in acute gouty arthritis: the optimum dose?
Varughese GI, Varghese AI.
Arthritis Res Ther. 2006;8(5):405. No abstract available.
Related citations
Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: a rationale for use of low-dose colchicine.
Chia EW, Grainger R, Harper JL.
Br J Pharmacol. 2008 Mar;153(6):1288-95. Epub 2008 Feb 11.
Something old, something new--colchicine in the 21st century.
Cronstein BN.
Curr Opin Investig Drugs. 2009 Nov;10(11):1141-2. No abstract available.
Casebook: polyarthropathy.
Coady D.
Practitioner. 2002 Nov;246(1640):715, 718, 721 passim. Review. No abstract available.
Colchicine induced toxicity and pancytopenia at usual doses and treatment with granulocyte colony-stimulating factor.
Yoon KH.
J Rheumatol. 2001 May;28(5):1199-200. No abstract available.
Stopping progression to tophaceous gout. When and how to use urate-lowering therapy.
McDonald E, Marino C.
Postgrad Med. 1998 Dec;104(6):117-20, 123-4, 127.
Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study.
Schlesinger N, Mysler E, Lin HY, De Meulemeester M, Rovensky J, Arulmani U, Balfour A, Krammer G, Sallstig P, So A.
Ann Rheum Dis. 2011 Jul;70(7):1264-71. Epub 2011 May 3.
A swollen knee.
Usatine RP, Sacks B, Sorci J.
J Fam Pract. 2003 Jan;52(1):53-5. No abstract available.
[What is your diagnosis?].
Chatterjee B, Henning L.
Praxis (Bern 1994). 2011 Feb 16;100(4):207-8. German. No abstract available.
[Why anti-gout agents when patients with gouty arthritis are to be surgically treated].
Hørslev-Petersen K.
Ugeskr Laeger. 1998 Apr 6;160(15):2233. Danish. No abstract available.
Treatment of acute gouty arthritis: one physician's approach and where this management stands relative to developments in the field.
Wortmann RL.
Curr Rheumatol Rep. 2004 Jun;6(3):235-9. Review.
Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis.
Borstad GC, Bryant LR, Abel MP, Scroggie DA, Harris MD, Alloway JA.
J Rheumatol. 2004 Dec;31(12):2429-32.
[Gouty arthritis].
Yamanouchi T.
Nihon Rinsho. 2003 Jan;61 Suppl 1:213-8. Review. Japanese. No abstract available.
Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study.
So A, De Meulemeester M, Pikhlak A, Yücel AE, Richard D, Murphy V, Arulmani U, Sallstig P, Schlesinger N.
Arthritis Rheum. 2010 Oct;62(10):3064-76.
[Diagnosis of gout].
Pascual Gómez E.
Med Clin (Barc). 2004 Dec 4;123(20):798. Spanish. No abstract available.
Urate crystals, inflammation, and colchicine.
McCarty DJ.
Arthritis Rheum. 2008 Feb;58(2 Suppl):S20-4. No abstract available.
Colchicine in acute gout: optimal dose of colchicine is still elusive.
Cox AR.
BMJ. 2004 Jan 31;328(7434):288; author reply 289. No abstract available.
Use of intravenous colchicine in patients with acute gout.
Stephan WH.
Am Fam Physician. 2000 Apr 15;61(8):2343-4. No abstract available.
Intravenous colchicine use in crystal-induced arthropathies: a retrospective analysis of hospitalized patients.
Maldonado MA, Salzman A, Varga J.
Clin Exp Rheumatol. 1997 Sep-Oct;15(5):487-92.
Gouty arthritis: understanding the disease state and management options in primary care.
Sunkureddi P.
Adv Ther. 2011 Sep;28(9):748-60. Epub 2011 Aug 31. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on